Novo Nordisk Foundation commits US$60 million to strengthen CARB-X efforts against antimicrobial resistance
Four-year renewed commitment will help advance the development of much-needed products to prevent, diagnose, and treat dangerous bacterial infections HELLERUP, Denmark and BOSTON, Nov.
